Valisure’s Co-Founder & President, David Light, was honored to present at this year’s State of the Science: Health Services Research in the MHS 2025, hosted by the Uniformed Services University (USU).

David’s presentation focused on emerging findings from Valisure’s Cooperative Research and Development Agreement (CRADA) with the Department of Defense (DoD)—a partnership aimed at evaluating the quality and consistency of critical medications used within the Military Health System.

His session highlighted the importance of independent chemical testing in detecting impurities and inconsistencies in pharmaceuticals, showcasing how such methods can support drug procurement decisions, protect service member safety, and increase confidence in the medication supply chain.

Following his presentation, David participated in a panel discussion moderated by Dr. Irwin Lucki, alongside fellow panelists Dr. Marina Socal and Dr. Marta E. Wosińska, further exploring the implications of pharmaceutical quality assurance and its role in strengthening healthcare systems.

Valisure is proud to support the Department of Defense and Uniformed Services University in their mission to strengthen military health outcomes and system resilience.

‍

Valisure’s Co-Founder & President, David Light, was honored to present at this year’s State of the Science: Health Services Research in the MHS 2025, hosted by the Uniformed Services University (USU).

David’s presentation focused on emerging findings from Valisure’s Cooperative Research and Development Agreement (CRADA) with the Department of Defense (DoD)—a partnership aimed at evaluating the quality and consistency of critical medications used within the Military Health System.

His session highlighted the importance of independent chemical testing in detecting impurities and inconsistencies in pharmaceuticals, showcasing how such methods can support drug procurement decisions, protect service member safety, and increase confidence in the medication supply chain.

Following his presentation, David participated in a panel discussion moderated by Dr. Irwin Lucki, alongside fellow panelists Dr. Marina Socal and Dr. Marta E. Wosińska, further exploring the implications of pharmaceutical quality assurance and its role in strengthening healthcare systems.

Valisure is proud to support the Department of Defense and Uniformed Services University in their mission to strengthen military health outcomes and system resilience.

‍